{"id":17942,"date":"2026-09-22T16:27:31","date_gmt":"2026-09-22T14:27:31","guid":{"rendered":"https:\/\/www.interpharma.ch\/blog\/erkenntnisse\/die-bevoelkerung-will-zugang-zu-innovativen-medikamenten\/"},"modified":"2026-10-21T08:50:16","modified_gmt":"2026-10-21T06:50:16","slug":"la-population-veut-avoir-acces-aux-medicaments-innovants","status":"publish","type":"steuerstudie","link":"https:\/\/www.interpharma.ch\/fr\/blog\/enseignements\/la-population-veut-avoir-acces-aux-medicaments-innovants\/","title":{"rendered":"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants."},"featured_media":17953,"menu_order":0,"template":"page-templates\/studie-gesundheitsmonitor.php","class_list":["post-17942","steuerstudie","type-steuerstudie","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants. - Interpharma<\/title>\n<meta name=\"description\" content=\"Pour la population, l\u2019acc\u00e8s aux m\u00e9dicaments innovants fait partie int\u00e9grante d\u2019une prise en charge de qualit\u00e9. C\u2019est pr\u00e9cis\u00e9ment sur ce point que le Moniteur de la sant\u00e9 2026 met en \u00e9vidence un d\u00e9calage entre les attentes et la r\u00e9alit\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants.\" \/>\n<meta property=\"og:description\" content=\"Pour la population, l\u2019acc\u00e8s aux m\u00e9dicaments innovants fait partie int\u00e9grante d\u2019une prise en charge de qualit\u00e9. C\u2019est pr\u00e9cis\u00e9ment sur ce point que le Moniteur de la sant\u00e9 2026 met en \u00e9vidence un d\u00e9calage entre les attentes et la r\u00e9alit\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-21T06:50:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/\",\"name\":\"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants. - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png\",\"datePublished\":\"2026-09-22T14:27:31+00:00\",\"dateModified\":\"2026-10-21T06:50:16+00:00\",\"description\":\"Pour la population, l\u2019acc\u00e8s aux m\u00e9dicaments innovants fait partie int\u00e9grante d\u2019une prise en charge de qualit\u00e9. C\u2019est pr\u00e9cis\u00e9ment sur ce point que le Moniteur de la sant\u00e9 2026 met en \u00e9vidence un d\u00e9calage entre les attentes et la r\u00e9alit\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png\",\"width\":1200,\"height\":627,\"caption\":\"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants: 72\u00a0% jugent probl\u00e9matique qu\u2019en Suisse, seule la moiti\u00e9 environ soit disponible par rapport \u00e0 l\u2019Allemagne. Source: gfs.bern sur mandat d\u2019Interpharma.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/erkenntnisse\\\/la-population-veut-avoir-acces-aux-medicaments-innovants\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Steuerstudien\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/steuerstudie\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants. - Interpharma","description":"Pour la population, l\u2019acc\u00e8s aux m\u00e9dicaments innovants fait partie int\u00e9grante d\u2019une prise en charge de qualit\u00e9. C\u2019est pr\u00e9cis\u00e9ment sur ce point que le Moniteur de la sant\u00e9 2026 met en \u00e9vidence un d\u00e9calage entre les attentes et la r\u00e9alit\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/","og_locale":"fr_FR","og_type":"article","og_title":"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants.","og_description":"Pour la population, l\u2019acc\u00e8s aux m\u00e9dicaments innovants fait partie int\u00e9grante d\u2019une prise en charge de qualit\u00e9. C\u2019est pr\u00e9cis\u00e9ment sur ce point que le Moniteur de la sant\u00e9 2026 met en \u00e9vidence un d\u00e9calage entre les attentes et la r\u00e9alit\u00e9.","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/","og_site_name":"Interpharma","article_modified_time":"2026-10-21T06:50:16+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@interpharma_ch","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/","name":"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants. - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png","datePublished":"2026-09-22T14:27:31+00:00","dateModified":"2026-10-21T06:50:16+00:00","description":"Pour la population, l\u2019acc\u00e8s aux m\u00e9dicaments innovants fait partie int\u00e9grante d\u2019une prise en charge de qualit\u00e9. C\u2019est pr\u00e9cis\u00e9ment sur ce point que le Moniteur de la sant\u00e9 2026 met en \u00e9vidence un d\u00e9calage entre les attentes et la r\u00e9alit\u00e9.","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/moniteur-sante-acces-medicaments-innovants-image-apercu-fr.png","width":1200,"height":627,"caption":"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants: 72\u00a0% jugent probl\u00e9matique qu\u2019en Suisse, seule la moiti\u00e9 environ soit disponible par rapport \u00e0 l\u2019Allemagne. Source: gfs.bern sur mandat d\u2019Interpharma."},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/erkenntnisse\/la-population-veut-avoir-acces-aux-medicaments-innovants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Steuerstudien","item":"https:\/\/www.interpharma.ch\/blog\/steuerstudie\/"},{"@type":"ListItem","position":3,"name":"La population veut avoir acc\u00e8s aux m\u00e9dicaments innovants."}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/17942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/steuerstudie"}],"version-history":[{"count":9,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/17942\/revisions"}],"predecessor-version":[{"id":18048,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/steuerstudie\/17942\/revisions\/18048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/17953"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=17942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}